Previous 10 | Next 10 |
PRINCETON, N.J., April 30, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that a post hoc analysis of the Phase 3 SECURE Trial evaluating the safety and efficacy of Twirla ® (levonorgestrel and ethinyl estra...
Agile Therapeutics Inc. (NASDAQ:AGRX) traded today at a new 52-week low of $1.71. So far today approximately 388,000 shares have been exchanged, as compared to an average 30-day volume of 1.9 million shares. Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet heal...
PRINCETON, N.J., April 20, 2021 (GLOBE NEWSWIRE) -- In a release issued earlier today by Agile Therapeutics, Inc. (Nasdaq: AGRX), please note the headline should read "Agile Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update on Tuesday, May 4, 2021" inst...
PRINCETON, N.J., April 20, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it will report first quarter 2021 financial results after the market close on Tuesday, May 4, 2021 as follows: Investors interest...
Agile Therapeutics Inc. (NASDAQ:AGRX) traded today at a new 52-week low of $1.76. So far today approximately 388,000 shares have been exchanged, as compared to an average 30-day volume of 1.9 million shares. Agile Therapeutics Inc. has overhead space with shares priced $1.79, or 9.6% bel...
Agile Therapeutics Inc. (NASDAQ:AGRX) traded at a new 52-week low today of $1.75. So far today approximately 388,000 shares have been exchanged, as compared to an average 30-day volume of 1.9 million shares. There is potential upside of 10.6% for shares of Agile Therapeutics Inc. based o...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Insiders are people who have access to private information about a company and can do something called insider buying . They include a company’s senior management, members of the board of directors and other importa...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips The bubble has burst. Penny stocks are falling like autumn leaves. The Reddit crowd and the day-trading community have learned a few difficult but needed lessons. First, it’s difficult to make money in the stock ma...
Hall of Fame Resort & Entertainment Company (HOFV) +71% after NFT deal.Dolphin Entertainment (DLPN) +66% after NFT deal.Alithya Group (ALYA) +52% on acquisition of R3D ConseilColor Star Technology (CSCW) +41%.Aptose Biosciences (APTO) +39% on Q4 results.Cinedigm C...
Evofem recently launched the first new non-hormonal birth control option in decades. Clinical efficacy falls short of the copper IUD, PARAGARD, but that device I believe may come with significant side effects. A trend in birth control centered on the woman's quality of life (safet...
News, Short Squeeze, Breakout and More Instantly...
Agile Therapeutics Inc. Company Name:
AGRX Stock Symbol:
NASDAQ Market:
Agile Therapeutics Inc. Website:
First Quarter Net Revenue Increased 58% and Factory Sales Increased 3% from Fourth Quarter 2023 Twirla First Quarter 2024 Demand Rebounded 18% from Fourth Quarter 2023 PRINCETON, N.J., May 15, 2024 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Pink: AGRX), a women's healthcare com...
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Full Year 2023 Net Revenue Increased 80% from 2022 While OPEX Decreased 33% Twirla Demand and Factory Sales Up 121% and 114% Respectively in 2023 vs 2022 Company Completes Pay-Off of Debt Facility in First Quarter 2024 Twirla Demand Expected to Rebound in First Quarter 2...